Artax Biopharma

Biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Launch date

2013

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	Keith Ventures	N/A	-
Sep 2013	N/A	$1.3m	Seed
Oct 2013	N/A	$2.0m	Seed
Oct 2014	N/A	$2.0m	Series A
Sep 2015	Lysosomal Therapeutics Advent Life Sciences	$10.0m	Series B
Jun 2016	N/A	N/A	Early VC
Jul 2019	N/A	$750k	Early VC
Jun 2020	Columbus Venture Partners	N/A	Series B
Dec 2021	N/A	$12.7m	Late VC
May 2022*	Columbus Venture Partners Advent Life Sciences Belinda Termeer Sound Bioventures	$26.0m	Late VC
Aug 2024*	Columbus Venture Partners Advent Life Sciences Eli Lilly Belinda Termeer Sound Bioventures	$8.0m	Convertible
Total Funding		CAD85.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Artax Biopharma